Boundless Bio Inc (BOLD)
3.58
-0.12
(-3.24%)
USD |
NASDAQ |
Nov 13, 16:00
3.60
+0.02
(+0.56%)
After-Hours: 20:00
Boundless Bio Price to Book Value: 0.4445 for Nov. 13, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 0.4445 |
| November 12, 2024 | 0.4594 |
| November 11, 2024 | 0.4445 |
| November 08, 2024 | 0.4345 |
| November 07, 2024 | 0.4122 |
| November 06, 2024 | 0.3936 |
| November 05, 2024 | 0.3712 |
| November 04, 2024 | 0.3613 |
| November 01, 2024 | 0.37 |
| October 31, 2024 | 0.3625 |
| October 30, 2024 | 0.3625 |
| October 29, 2024 | 0.3886 |
| October 28, 2024 | 0.3725 |
| October 25, 2024 | 0.3625 |
| October 24, 2024 | 0.3712 |
| October 23, 2024 | 0.375 |
| October 22, 2024 | 0.3762 |
| October 21, 2024 | 0.3762 |
| October 18, 2024 | 0.3787 |
| October 17, 2024 | 0.3762 |
| October 16, 2024 | 0.3774 |
| October 15, 2024 | 0.3774 |
| October 14, 2024 | 0.375 |
| October 11, 2024 | 0.375 |
| October 10, 2024 | 0.3638 |
| Date | Value |
|---|---|
| October 09, 2024 | 0.3601 |
| October 08, 2024 | 0.3787 |
| October 07, 2024 | 0.3948 |
| October 04, 2024 | 0.3948 |
| October 03, 2024 | 0.3886 |
| October 02, 2024 | 0.3874 |
| October 01, 2024 | 0.4047 |
| September 30, 2024 | 0.4308 |
| September 27, 2024 | 0.4209 |
| September 26, 2024 | 0.437 |
| September 25, 2024 | 0.4283 |
| September 24, 2024 | 0.4209 |
| September 23, 2024 | 0.4594 |
| September 20, 2024 | 0.5463 |
| September 19, 2024 | 0.5301 |
| September 18, 2024 | 0.4308 |
| September 17, 2024 | 0.4246 |
| September 16, 2024 | 0.4681 |
| September 13, 2024 | 0.4457 |
| September 12, 2024 | 0.3985 |
| September 11, 2024 | 0.3812 |
| September 10, 2024 | 0.401 |
| September 09, 2024 | 0.3973 |
| September 06, 2024 | 0.3886 |
| September 05, 2024 | 0.3973 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3576
Minimum
Aug 12 2024
0.555
Maximum
Jul 08 2024
0.4288
Average
0.4215
Median
Price to Book Value Benchmarks
| CEL-SCI Corp | 4.573 |
| AIM ImmunoTech Inc | 2.511 |
| IGC Pharma Inc | 3.525 |
| NovaBay Pharmaceuticals Inc | -- |
| Protalix BioTherapeutics Inc | 3.191 |
Price to Book Value Related Metrics
| Price | 3.58 |
| Earnings Yield | -396.0% |
| Market Cap | 79.67M |